Target 17

Strengthen Biosafety and Distribute the Benefits of Biotechnology

Establish, strengthen capacity for, and implement in all countries in biosafety measures as set out in Article 8(g) of the Convention on Biological Diversity and measures for the handling of biotechnology and distribution of its benefits as set out in Article 19 of the Convention.

Property 1=17

Establish, strengthen capacity for, and implement in all countries in biosafety measures as set out in Article 8(g) of the Convention on Biological Diversity and measures for the handling of biotechnology and distribution of its benefits as set out in Article 19 of the Convention.

Target 17
Target 1 Target 2 Target 3 Target 4 Target 5 Target 6 Target 7 Target 8 Target 9 Target 10 Target 11 Target 12 Target 13 Target 14 Target 15 Target 16 Target 17 Target 18 Target 19 Target 20 Target 21 Target 22 Target 23
ar
en es fr ru ar
but-4398696

Rationale

GSAP

Controlling and managing release of genetically modified organisms and other biotechnology products reduces potentially severe impacts on species, their habitats, and people.

Primary tools and resources

View all

The Cartagena Protocol on Biosafety

The Cartagena Protocol on Biosafety is a supplementary international agreement to the Convention on Biological Diversity which aims to ensure the safe handling, transport, and use of living modified organisms (LMOs) resulting from modern biotechnology that may have adverse effects on biological diversity, taking also into account risks to human health. It was adopted on 29 January 2000 and entered into force on 11 September 2003.

The Protocol establishes an advance informed agreement (AIA) procedure for ensuring that countries are provided with the information necessary to make informed decisions before agreeing to the import of such organisms into their territory. The Protocol also establishes a Biosafety Clearing-House to facilitate the exchange of information on living modified organisms and to assist countries in the implementation of the Protocol. The Biosafety Clearing-House is an online platform for exchanging information on living modified organisms and is a key tool for facilitating the implementation of the Cartagena Protocol. It includes national information published by countries (primarily Parties to the Protocol) as well as virtual library of biosafety resources, information on different living modified organisms as well as laboratories for their detection.

How to use

Further information on the Cartagena Protocol is available at: https://bch.cbd.int/protocol

The Biosafety Clearing House can be accessed at: https://bch.cbd.int/en/

View all

Other tools and resources

View all

BIOSAFETY CLEARING-HOUSE

The Biosafety Clearing-House (BCH) is an online platform for exchanging information on Living Modified Organisms (LMOs) and a key tool for facilitating the implementation of the Cartagena Protocol on Biosafety.

View all